0000105770-23-000054.txt : 20230921 0000105770-23-000054.hdr.sgml : 20230921 20230921163325 ACCESSION NUMBER: 0000105770-23-000054 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230425 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230921 DATE AS OF CHANGE: 20230921 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 231269476 BUSINESS ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 8-K/A 1 wst-20230425.htm 8-K/A wst-20230425
0000105770false530 Herman O. West DriveExtonPA00001057702023-04-252023-04-25

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K/A

CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) – April 25, 2023
wstlogoq319.jpg
WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania
1-8036
23-1210010
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
530 Herman O. West Drive, Exton, PA
19341-1147
(Address of principal executive offices)
(Zip Code)
 Registrant’s telephone number, including area code: 610-594-2900
Not Applicable
(Former name or address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, par value $0.25 per shareWSTNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

1

Explanatory Note:

This Current Report on Form 8-K/A (this “Amendment”) is being filed to amend the Current Report on Form 8-K filed by West Pharmaceutical Services, Inc. (the “Company”) with the Securities and Exchange Commission on April 25, 2023 (the “Original Form 8-K”). The sole purpose of this Amendment is to disclose the Company’s decision regarding how frequently it will conduct future shareholder advisory votes to approve the compensation of its named executive officers (commonly referred to as a “Say-on-Pay” advisory vote). This Amendment does not otherwise amend, modify, or supplement the Original Form 8-K.

Item 5.07 Submission of Matters to a Vote of Security Holders.

Based on the results of the shareholder vote at the Company’s 2023 Annual Meeting of Shareholders held on April 25, 2023, including the shareholders’ non-binding recommendation to hold future Say-on-Pay advisory votes annually, the Board of Directors of the Company has determined that future Say-on-Pay advisory votes will be conducted annually until the next required advisory vote, which under current Securities and Exchange Commission Rules is expected to be our 2029 Annual Meeting of Shareholders.

Item 9.01 Financial Statements and Exhibits.

(d)
Exhibit No.
Description
 104
The cover page from the Company’s Current Report on Form 8-K/A, dated April 25, 2023, formatted in Inline XBRL.


2




SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


WEST PHARMACEUTICAL SERVICES, INC.
/s/ Kimberly Banks MacKay
Kimberly Banks MacKay
Senior Vice President, General Counsel and Corporate Secretary
September 21, 2023



3





EXHIBIT INDEX

Exhibit No.
Description
104
The cover page from the Company’s Current Report on Form 8-K/A, dated April 25, 2023, formatted in Inline XBRL.

4
 EX-101.SCH 2 wst-20230425.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 wst-20230425_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Type Document Type Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 4 wst-20230425_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 5 wst-20230425_g1.jpg GRAPHIC begin 644 wst-20230425_g1.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_[ 11'5C:WD 0 $ / _]L 0P " M 0$" 0$" @(" @(" @,% P,# P,&! 0#!0<&!P<'!@<'" D+"0@("@@'!PH- M"@H+# P,# <)#@\-# X+# P,_]L 0P$" @(# P,& P,&# @'" P,# P,# P, M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\ M$0@ A %) P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08' M" D*"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2E MIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S M]/7V]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 M (! @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC M,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*S MM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: M P# 0 "$0,1 #\ _?RBD#Y[4*VXT7 6BBD)QVI)I@+12$XHSS3N M%(S[3T MI#)B@!U%-\SVI0V31<+BT44A;!Q2N@%HI V32T[@%%%% !1110 4444 %%%% M !1110 444A.!0 M%('R.>*3?2N ZB@'-%.X!1110 444C-MH 6JT\P#NOZG MITJ26? &.OIZ^U?EO_P5\_X*G^$/&4&M_!7P3\8-.\"W=O?2Z7XQU@:!J&IN M%50KV=M);+L#!BRS,7#*8R@&=Q'H99EM;'5U1HI^;2;LN^AYV9YE1P5%U:K7 MDF[7?;4\>_X+6?\ !9>^^(&NW?PD^#7B&^TC2M&NMNN^*-*NWAGOKF%^+>VD M7D0HZ@NX)\PJ%^[G=^DW_!,K]LRW_;F_8[\*>-Y?L\?B!8O[-\16\/W;;4X, M)/@=DD.)4'/R2J"<@U^ MM^SS\"K&9;>Z_::\L(,?Z#\)M4N$'IAFNTS[_+^ M-?8O_!%#]HWX;?L??M12>#=,^,^H^--!^*#1::+*?P#<:'!;:DI_T:Y\Z6]F MVAE+PL/+!8M%T"YK])S[A_ K*E1P,)>TI:W<)+F_FNVK>:[6L?G>1Y[C?[4= M7&U(\E32RDO=?2R_,_;N,AAD'.:=GFJDMPT,;$L%"Y+$]%QU.:\G\'?MS_#+ MQ[KNEV>D^*&N(-Q^HSK4X64VE<]CHIB.2[=QGBGU!H>'_M:?\%"OA9^Q!=^'X/B1X@DT M-_%"W#Z>%M))_.$'EB0G8#C'FIU]:\C'_!?/]E_.?^$^GYZ?\2FY_P#B*^)O M^#I;5?/^,'P7L0ZYM]'U6X*C[P\R>V4$^W[OCZ&ORR()7[S'\:_6>'.!,#C\ MOIXNM.2E*^UK;^C/R;B+CO&8#,*F$I1BXQMO?LC^B8_\%]/V7Q_S/UQS_P!0 MJY_^(KZ*_9O_ &G?"/[67PLM/&G@;4)-5\.WT\MO!)RC_ "N "AX+_P""7WPDC8DM?Z6^J$=/^/B:2;'_ (^* M\OC+A+!Y3A(5L/*3E*5M;;6;/3X/XLQF:XB=*O%)15]/4^C?BE\3]&^#7P\U MGQ3XBO$T_0M LY+Z^N7&1##&,LV.IXZ =Z^4X_\ @OK^R^R!O^$]N5R,\Z3< M@_\ H%>:?\'(G[1Q^%_[%FF>"K6*VX1X)P^98-XK$RDKMVM;9>J[F/%O&M?+<8L+AHIV2;OY_,_HF/ M_!?/]E_&?^$]G/\ W";G_P"(KVW]DS]N;XH_#G69=:L?#UW'8WTK MVLD CE>,2*HW@9^0@\=,BOY;2#MY=L ^M?MC_P &NOAZ2Q_90^).IN"$U3QK MA#S@^586L9[>M:\5\%8'+,O>+H2DY)I:M=?D9\)<:8S-,>L-6C%1LWHGT^9^ MG7IMPZ!XW*-A@F",J>1P M:]=_;\^/@_9C_8_^(/C=95BO-'T:?[$2VW-S(OEPX/'.]@>/2OY23[DY)KS>"^$J6;0JU<2VHQ:2M;?KO\ (]'C+BRIE,Z=/#I.4KMW M[=/U/Z)_^'^G[,&?^1^G_P#!3<__ !%=%\'O^"S'[/\ \?/BCHO@WPKXMN]5 M\0^(;@6MC:II=POF/M+./CMX MR^+>I1,=/\%6BZ'I#%]G_ /E>78&IB^> M;:6FJU;VZ=SPL@XWS+,L=3PBA&S>NCT77J?MC!)YOMBIJ9%$(R<=Z?7Y%<_6 MTPHHHIC"BBB@ HHHH **** "BBB@ JKJNJPZ1:R37,L4$$*&22:5@B1J.2Q) MX [DU9(]Z^4_P#@M?\ %@?"'_@FC\4;P.B7&L:?'H5OD_>>[F6 C_OEF_*N MG!89XG$0P\=Y-+[V]+^T%X%9?\ D<_"?/\ U%[?_P"+ MI?\ AH'P*/\ F=/"G_@WM_\ XNOY-QI%JJ ?9XN#@?(!0VD6HZP0_P#? K]7 M_P"(60Z8A_\ @/\ P3\F_P"(I3O_ +NO_ O^ ?UJ>'OB_P"%?%FK1V.F>)= MU&\ERT=O;:C#+*X R<*K$G Z_2NFK\*?^#8GX)P>)?VS/&'C*2SB\KP?X:^R MV\FP?)/=S*,@]B(HI!]&K]UJ_/.(LGAEF->$A/FLEK:V_0_1N',VJ9E@EBYP MY;MZ7N%%%%>$>Z%03W #%,9..*)I2J<,!SU/0U^:?_!;C_@L4W[-]E>?"/X7 MWT4GQ%OX0NN:O&X<>%X'7/EIV-W(I& >(U.X_,5%>AE668C,,1'#897;^Y+J MV>=F>:8? 8>6(Q#LE^+Z)>;-K_@LO^V_\4=&TB[^$?P.\%^--6UW48Q#X@\1 MZ7IEQ)'ID+K_ ,>]LZK@SN#\S@_NQG^(_+^1FD_\$WOC]=K'':_!;XCA#\J[ MM$FC5>,XY'':O.-+^*WB[02/L7BSQ1:D;CF+5;A"2QRQR&[G)/O6O;?M6_$S M3@HB^)_CN$( %\0W0"@=!C?TK][R?A_$95AU0PCAKNVG=O[_N/P3.,_H9K7 M=;%J=ELDUI^!ZCI?_!)K]I/5P#%\&_%Z#;G]] D.1]&8?E6#=_\ !/+]H+PY M.D__ J7X@V=Q:,DT4T>F/F%U(96!'<$ _E5#2O^"C'QN\.?/:_&CQU!M.XD MZY(P!QC^(GM7"?$K]IOQ3\8/%LVM>*?'^L:WK-V%CDN+G5F\R0* JC 8#. ! MT[5Z=)9IS-5I4^7R4O\ ,\^:RQ14J,*G,O-?Y']"/@+Q9XT_;M_X)8:Q97^A MWF@_$G4_#D^A:KIFH VCSWR1A)%+$ JEP 1GH!*>V:^5X/@UJGQ#^.7BJ^TW MPW?W=_\ $"[UJTMM _LK^SM2\.F5+*.TEU*8J#)90)%+MA+E8)8;9XU;<#'\ MT?\ ! K]N*3]G/\ ;"_X0SQ#JBUZ?)KUTWLS]CR:=+/, M'#$.34H^[)==.OJT_P"K(CT&UDLM.@AED,TL4:(\IZRD* 6_'%7J9'"(\]3F MGU\3KU/N$K*Q^''_ = :CYW[7/PTL@25M/"$LH&.%,EXPZ^X3]*_-4'+#OZ MFOT$_P"#E35CJ'_!0?1K8DXL?!MF"-V<%[BX;D=NGXXK\^P<5_2W!L.7)J'I M^;9_-7&<^;.*]N]OP*^JEH["8J.^#_ %K^JS]D#P6OPY_9,^&VA)'Y M1TSPS86^S&,,+=,_KFOY:_!^@'Q;XTT/20"6U34;:S^GF3*O]:_JA^-'Q;TG M]F/X"^(_%^L-_P 2CP/HLVH3QJP5ID@BR(USQN<@*N>["OBO%">B1]KX804(XBO+965_O9^&7_!PA^T8OQN_X*!WOAVUG$NE?#+3TT.)0256Z MDQ/M7?%'B_5/B'XHU3Q%KEPMUKOB*^N-6U.11@27 M5Q(9I2!V7>Y '8 #M5 MGL<=*_2,GP,<%@:6%7V4E\^OWL_-\ZQKQN.JXG^9 MO[NGX"D9-?O7_P &W&D'3O\ @F^ERRX-_P"*]5GR?X@'1 ?_ !S%?@IC=T(K M^B/_ ((-Z.-"_P""6GPX.W:U\VH7;#&-V^]FP?RQ7QGB9/ERR$>\U^3/LO#* M%\RG)](_JCPS_@YS_: /A3]G+P1\/;68I<^,]6>_O$5\'[+:*#S[&25/Q6OQ M/0 XQQD_E7VC_P %]OC^OQO_ ."BVOZ7;R^9IOP\LX?#L(!ROG#]]<$>^^0* M1_TSZ\U\7$;5STP*]G@G ?5%[F#R=:O+3^V=9XP?MMU^^D! M_P!P%(Q[1CI7X5_\$H_V85_:W_;R\"^&;FW^T:)I]S_;NL KE/LMJ1)M;V>3 MRT_X$:_H4_:J_:[\!?L7_"V7QA\0=S^&FE:?\ #70 Q$,\H34=6G7LSNP\ MJ(G^ZBMCIN/6OC3XA?MA_%KXM7)G\2_$_P ?:M(6+8DUN=$7)SA51E 'L*\7 M+_#;,:T>:O*-._3=_AI^)[..\25Z=\'/^"B_QU^ 5Y#+X9^*G MC&&*'_EUO;]K^U?ZQS;@?YUVUO"[$J-Z5=-^C7ZLXZ7BCA7*U2A)+U3_ $1_ M4/%-Y@SC']:=O%?G-_P21_X+=)^VIXH3X<_$6PT_PY\0S 9=,O;,E;'Q$$&9 M%"'F&< %MF2K+DJ1C;7Z*&01D<@#.!S7YYF>6XG 8AX;%1Y9+[FNZ9^@Y;F> M'Q]!8C"RO%_>O)^9+YB^M,EG"8P-VXX^M?/_ .WM_P %%_A]_P $^/ *:SXQ MO)KK5=25QH^A6.'O]6=1SM4\)&"0&D?"C<.I(!_'']IO_@X,^/?QWNKB#PU> MV'POT1V*QVVCXN+P(>F^ZD7);&.41![5Z^1\)YAFBYZ$;0_F>B^7?Y'DYUQ9 M@,L]RM*\_P"5;_/L?T&?:'X_=F@W#C_EF37\HWC']HWXC?$:_>[UWXA>.=7G M?EGN=_:%_ M9_OX9-%^)WB#4+6#'^@ZW+_:=JRC^$K+E@#_ ++ ^]?L5_P2@_X+#:3_ ,%$ M([SPOKNEVWA7XE:+9_;9[&&(Y*[E.Y@"ZL]X#SWA%;_P#P7V_X*.?$;]CGQ-\- M?#?PS\1KX?U'6(+W4M4F6WAN'DA4QQPH5D4A1N,ASWVXK\C?VG?VP/B+^V7X MFTO5_B/XA/B'4-$M'L;.4VL4'E1,^]AB-0#EL')S7N<$<)8B=6AFLVO9IMI= M=+I:>OF>'QKQ9AJ=&MED$_:/2_36WZ'FL;?NU)QD\T$Y!]:55V_C01N&!R17 M[OTQWCUK^8 M_P""G_!5;X\?LQ_"BQ\(>"?&_P#8OAS1EE:VM%TRWD*EV,C99E+$EB>I[U_0 M[^Q3J?BG7?V2_AQJ'C?49-6\7:IX>L[[5KIX4A9[B:)96!10 ,;]O']VOY_X MYR7$X?%RQV(E&U23LDW?3Y=C^@^!LZPV(PD<%0B[TXJ[=K7^\]3+ &D9QM/T MICR+$,L< U\>?\%._P#@J7X+_8XTZ7P7#XUL]!^).N67FV,6=F)+$Y)))S6 MG?\ P7^!WC7Q1>ZKXA_:NUC4=6UFZDO+^^E^%6HO-=3R-N:5V>[.22223^%= MSX._8R_9.UR-!?\ [8=[9NPY\SP#-; $=?O.^ >W]:_:\HP.5Y;AE3G"I*37 MO24*BN_E;1'XSFN.S3,L6YPG345\*%D0-^Q1\'90LADRL\,F.,#'FVC<_I]*T?# MG[ '[$=U*!=?MB7G6MZ5?U9=#!YXY>[4HW]:?Z(P?#G_ 71 M^"&D/YK?L:^ [";85+V2Z;D\],_8UX_SBO4M*_X.2O@_'HMUID_P(UVSTZ_C M-M=6]NU@T4T3+M9'4!0PP2-IZBMCPC_P1\_85U95%O\ &"TUQF0$>5\0K$[L M=6_=GI7J'A+_ ((4?LCWJ;[&*YUQ!B;/_"6M,NT_=^XWW3V-?-5\3PQ?^%5^ M^7ZL]ZAAN)MO:TO_ "5_H?DE\4/VQO!NH^,]47P?\"/@YI?AU+V1]&>XTB^7 M4+>WW9A$C1WH42I\IW+C!48 [?NY_P $L?VVX_V\OV0?#WB^[%K!XIT__B3^ M);6 XC@U"$*'=%.2J2J4E0')"R8R2I)^ ?\ @K;_ ,$G_P!G/]F+P3X/\2V? MBO7?A/I=Y=RZ5)_9^@3^)QJUP4,R[OWZ>2P5'P2<-Z9%<'_P1C_:.^&/[&?[ M6;Z!I'QAU[Q3H'Q,,&CSV5YX"?1[<7BL?LMS]H:_D\LC=)&P,1W>8.@ -=F> M4<#FV4JO@(3YX7M=2>BW5W=>>C.;)<1C,JS1T,?.'+/M9:O9V5GY'[H @=Z6 MJ]N[,S \D5+GV%?DEGT/U=RMN?SX_P#!Q%J@U'_@IUK,8*DV?AO2KE?7W_!>35#J7_!4[XB EV%I;Z9;J&Y Q91MQ_P!]U\@DU_3O M"\.7*K?$_5MCJIZV%D4FG)]C(]LF/\ ;/I7 MYT_\$+O!_P#PF?\ P4Z^'H.=NDI=ZB?^V<# ?JU;'_!?/]HMOCM_P4+UK289 MO,TKX=6D?AVU4'&J]1?%5ERK[M?PN?%I8G;@ $UZ+\:?@VOPF^%/PJO9U*ZIXXT2Y\ M1S$\%;=[MX;8$>Z0,W_;2N4^&GPUU+XT?$?0/"&D*S:GXGU"#2[8CJCS.$W? M1023]*^N?^"].B6'@+]MG2?!6DH(M*\!^"M(T2T3 &V-$8K^F/QS7U>)QKCF M%'!QWDI2?HEI^+_ ^7PF O@*V+ELG&*]7_P$?%A8(H89QW_SZU_1Y_P39\4: M?^S]_P $A/AKXDU5A#IGAWP/_;EZ78S,!RL M+L,?[I-?MI_P4Z^*R_LW_P#!![X>^$K5EBO_ !WH^B>&8T7J(3;++>$P.6)!EGD:1@,]@6P!V [5GNN3C.#G&:3!)R2*ZE'-OIMEN>5ESU\R9L8'4QJ* M_.']O3]MWQ-^W_\ M#7WC?Q#YUKIT1>V\/:0TF^/0[(MD1KT'F/M5I' !9@. MRJ!^@?\ P7+\3VO[&/[!_P 'OV:?#MT,7MJDVKRQY4W%M9A$P]+):3LH).=NLGK M^ O;H.:]+_99_8\^(W[9WC>Z\/\ PX\.2Z[>V$(N;V4RK!;6,;'"&65\*I8@ MX').UL @$UYH>!S7[_\ _!O-\"+7X3_\$[M%U\PQ_P!I_$34+K6;F7RMKO$D MK06ZD]P(XMP[?O"1UKT^+L_EE.!]O22?)'&H^F(B:_+4 M#:![UV<-YC7Q^7T\5B%:4KWMZV./B7+J.!S"IAL.[QB]/N-OX7?$N^^"WQ/\ M.>,-,E>VOO"VJ6VJ0R(<%3%(K,/H5W _6OZB_C_^T7H/[/7[.WB#XDZZ6_L3 M0=).J/&K //E 8XE/]YV*J/+M46XOMK8+P6%LIVD?W3-+$?^ "OD..,KACZ_LF_\$V_C+^VWH=YJWP^\)&^T6RE, M#ZC?7<=E:22C[T:/(1O9<\[0<="17%_M*_LL>.OV/OB6?"7Q#T-]#UHVZW<* M"9)HKJ%F91)'(I*LNY2/4$+ MI/B7<^%[30]&.GVL%GI$5]'=*\IE,WFF1<@@J ,<9R$S65#,X> MSHW=G9W?9WZW/T>'!6$Q>5QKY;/GK:-JZMYJW2Q_/KC'4<#UKW/_ ()B>-K[ MX>_\%$/@WJ.GNZ7#>)[>R;:<&2&XW02I]&C=@:_0S_B%=TAAQ\#M334X].?08;=;IT5@H:02L5 M)SP.U=F9<=9-6PE6BIMN46DN5[M>AS97P-G%#&4JLHI*,D]ULF?"'_!P+\9[ M;XC?\%+?$>FI=PF+P;IMEHB RK\KA#-(,?[TO/?BOC!&##I@]37]0'[5G@'X M54P2=H7[Q/2GU]3?\$5?@99_'[_@I'X$TS4[.#4-'T9+O7M0M[B%9 M898[>$A596R&4S2P@@^M?6YCC8X3#3Q4]5!-_B(JA0OX "N3T3]G+X=^%]3M]3T[P)X.T^_M'$MO=6VCV\4T+]F5E0$ M'W!KPK_@J)_P4W\/?\$ZOA*D\:V^N?$#7XG7P_H!D(\TC@W<^WE+>,]3U=B% M'.2/P;/L\K<18FC0PU)IJZ2O>[=M>G8_>L@R2CP]AJM;$U$T[-NW1=/Q-?\ MX*._MG^)_P!F+X3FU^'/@7Q!\0/B-KR/'I5EIEA)=0Z<,8^UW10'"*2-J=7/ M'0$C\*_%/[!'[47QK\=:OXEUOX5?%#6?$/B"\-UJ-]?:5(LEU._5RS8PH & M/E5551@ >0_%'XU^+OC)\2=8\7^)M?U6_\ $'B"Z:\O;O[0\.]R>%15("(H MX51PH ':LW3?BWX@T )]D\7>(;(HQ*F/69X]I/4C#]Z_3.'^%ZV4T;4)0]I+ MXFTV_16DM#\US_B>CFM;]]&?)'9)I?-Z/4][T_\ X) _M-ZG'NC^#GBE5.?] M:8(CQ[,X-='HO_!#C]J+6HMP^&LEI\H.+G5+:,\]OOGIWKY_L?VOOB-I40CM MOBKXY@10%"IXEN< #H/]972Z+_P4@^-^A/\ Z%\:?'\7(?\ Y#,L@R.!P2>* M]>LLZM[E2E]TO\V>5163;3I5?O7_ ,B>^V7_ ;Z?M0WDRA_"WAJV5VP6E\1 M0?+[D#)(KI-'_P"#;C]HO4U4W$_PYTTL&)\[69&*D'@?)">HYZ\9KQ/PY_P4 MV_:FGD#Z;\3_ (G:B0, )&]POS=./+.?:O2_"W_!2W]N654CL-1^)FHJPV*S M^"S/NVCGDV^,XZG->-B)<1I>[6H_<_U/8P\.'F[NA69WEC_P; _&N_F(O?%G MPG@4XRPFNYB?7(^SCI]:Z'3?^#4;Q;>LOV_XH_#VV4,<>5X8FNL#UYE3G/T^ MM8W@O_@H!_P41G*O;>&O&NKHW[Q1<^ P.._\"\?K7I'A_P#;G_X*1:@JQQ?" M%97#!/,N/" B/.2.LZC KPL5BN(T[?6:/WQ7YGT&#H9!NL/5^Z7Z,\Y_:%_X M-I/'_P "?@U>ZYX2\9Q_$?7K>>%8_#NE>'#8MP20XFCEAL=[1%3D,"I/S X/'/>OKG_ (*"_M>?MH:A M^QWKVG?&/X=:'X+\'ZO=6=G)K5HQL+V*=9UEC6,+<,3O:+!&,;2:_-F3Q/J. MJ,7DU?5;J1V+$M?RR9)')Y;O7T7#L\WK4).O6IRUZ+F_&+2_4^:XBAE5&NO8 M4JD=+ZZ?@TW^)_35_P $XOCGXF^.G[*'AC4/&_A_5_#?CG2[==+UZSU* PS/ MY?VB?[B_\ ??\ ]:OY\_\ @@[^VBW[+'[:5IX= MU>\=?"/Q15-#NO.D.RTOMV;.?GIEBT)'_38'^&OZ"O+G]!^M?C_%F2RRS'RI MOX9>\K;:[KKL]#]\?\%2-5&M_\%)OC?<(Q9?\ A+;B$'&,>6D?B?\3-2C#V'P MW\ WFIN2VWYVD147IU;!%?%GB7Q7?>._$NIZ]JG?"OXK?\*Q_8\^+&F6TY74?B)JNC:$T:D K9V_VF\G)]F98E_$UY&,JGTX% M8X+!VQM?%2WERQ7HE_FV:8_%_P"Q4,+':-Y/U;_R2/O7_@W8_9Z_X6_^W@_B MF[A633_AMI;ZEN8$@74Y,,'XX\QO^ UYS_P7%\3GQ-_P5$^)O)9=/DL[$<\? M);1D_D6_G7Z;_P#!N/\ L[CX4?L-R^+[B'9J/Q*U5[\,5PWV2 M# /<9$K#_ M 'Z_(G_@I;XE/B[_ (*#_&6^)W#_ (2R]@4YR"(G\L?HM?)Y1C?KW$^(J)W5 M./*OO5_QN?69Q@OJ7#6'IM:U)V&#T^;'WC7PWX"T^#6 M?B+X>M;EQ%;76JVL-79C'X@UN>6W&2 M<6ZL8X5SZ"-5%?5XK ^VS*A6DM*:E]\K)?A<^5P>-]CEM:A'>HXKY*[?XV/. M6('I@5]S?\&]O[+?_"_OV\HO$][!YNB?"BS&M3%ERCWTVZ&RC/H7O_J!Q MD@CX9+!3@G ZDYZ"OW]_X(!?LV1_LY?\$^[#Q/J5N+?5OB/,WBB[/QUFCPF5RC!^]4]U?/?\/S/7X$RSZUF<9R7NT_>?RV_$_, M#_@NK\:C\9/^"E'C2%)O-L_!T4'A^ 9R%,2;Y&,)&@9H2QPJ@9)).,D\UY3^S3^SYKG[57QX\.?#[PV]I'K/B M6X:""2Z++!#M1G9W*@G: IZ U]Q-_P &R?QS3=_Q5WPV"D_\_-U_\9KS<[Q^ M3TY1HYFXWW2DK^5]CT\DP&<2A*MEBE;9N+L?#W[0?[1WCG]JSQ\OB?XA>(+C MQ-KJ6J62W4L,<)6%"Q5 L:JH +,>G>N)"E>M?HJW_!LM\14H*G2K145LE>WY&]?A7/*LW4 MJTI.3W;_ .'/C;]BGX:'XR?MB_"_POL+IK'B>P253WC282O_ ..HU?I;_P ' M3GP_U&YT?X,>+HXV?2=/N]4T:XDVG]U/<);RQ GMN%M*![BM7_@F?_P0G^(G M[(O[8WASXA^-?$'@S4M(\.P7,D4&FR32SR7$D9C0X>-0% 9B3G.0.*_2?]H/ M]GOPI^T]\(M8\#^,])BU;P]KD7E7$).UT8'*2HPY61&^96'0U\%Q!Q;AXYUA M\7AWSPIIWM_>W_"Q]]D'"F(>2U\)B(\DYOKY;?B?REF:47>J>!8+GXI>#HBTDJZ'Y3F63 MXO!3=/$0:?X?)[,C,6X,K %6QD8X/M7KG[,W[=7Q?_8[N$_X5[X[UG0K%7$C M:6\GVK39.<\V\NY!GU4*?>O)FE"_Q+FEQGTXKJQ&%HXB#IUXJ47T:N''6#]EE"J/[;;_ $7Y M'QOB-C/:YJZ2^PDOU?YC7.,FOU._X-=/A-_:/Q9^+7CV:(;-(TJST"V?I7[V_P#!MY\)U\#_ /!/0Z])"JS^-?$-YJ!. M.6CB*VR9_P"_+?@16GB%C/891**WFTOU?X(S\/<'[;-XS>T$W^A]_3MBU!ZD M8S7X3_\ !:;7-9_9H_;[U^[\1?#WX7>.-/\ &$,6LZ+J?B+1+FZN#;*HB:UW M"Z"[87!&%4#]XAV@GG]W'0%"*^0O^"R7["6G?MM?LJ2H;EM*\1> I7U_2=0A MT\WLZHL;"ZMEB#(SB:+HH89DCB/.VOQ[A3,:.#S"#KJ\)>Z]6K7M9Z:_\ _8 M>*86X/;^M>A^#O\ @GM^ MP!J1C>7]I>^O5;,@\_58;/Q:9_P=,>!7VB\^$GCJ#@$BWU&SFY[]2G'OWKI=(_X.>/@S=?\?O@W MXEV(+;21;VTN!@<\2UPFC?\ !,/_ ()\7<4:CXT:;=L H_>?$"TC8D]#MXP3 M7IW@G_@D?^PSJ6T6&K:%KI=MB_\ %JOO7YL]Z MC6XEDTG7I?A^A?TW_@Y2_9YO''FVWQ&M,C.9-%#C/IE9#U]JZC2?^#AK]F2^ M0>9XE\0V?R@_O]"N.I[?*#R.]7M$_P""+O[(KR)<6W@?0[X+DC.OSS(P/?'F MD'^E=UH?_!(7]F;2;=5M_@QX'GV)M!FMC<'')!)9CR?7WKQ*\^'$O]U0G4M*\6Z5< M?9+&)(G*3JC* 9#(0J\]"U? 'C7_ (*4Z=XO$S_\,V_LTV?F!,LOAB5P"O'_ M #V /IBO;_\ @I3\,_V0M7_:1U+1M!\?R_"[_A$';1;_ $;PS\/_ +9;/=1L M?-D:<31B1@?EZ?+MQ7F7[(7_ 3,\&_MV_%]O"WPW^*?B[48M.B-UK&IW7@+ M[+::7#NPFZ4WA >3#"-,$DACC:K&OT+)L+DV$P/MJD)Q6[ECX#.,7 MF^+QWL:52$GLN6WZW9TO[ 7PA\0?\%,OC(^@Z5\(/@;X6\)Z.Z3^(O$-EX6G MC;2HB[ &>_G('F7,S?QRN1DD_08 KT'^S8_[B?K7YAQ!G:S M#$7HKEIQTBM7\W=[L_3,BR5X+#J-=\U1[O1?+1=#^6+]MG5FUW]MKXS73;MS M^/-<3EMQ/EW\\77_ ( /ITKS,Y,?O7:?M+7L>K?M0?%&]B*F&\\<^(+E&7." MLFJW3C'X'O7&+T]*_H[+8N.$I1>EHQ_(_G3-K?7:MG=$M!1'UOQ3J5OHVG[P=BSW$JQ(S8YVJ6W-C^%6/:LL@XR*^[O\ M@W:_9V_X7/\ M^)XIN8A)I?PNTJ35I&9,J;RX+6]JOLWO7U%6N9<&6Y)F?!_B8[ MC^IK\Q\+8.57$UI:OW5][9^E^*$HQHX>C%66OZ#G!(XZC\#2*<)BG#GZXI&& M?J3U-?L*1^/7Z'H/[*?[/%W^UA^TCX-^'5H' \5ZE':73J.8;4'=YK&OF]/#7]VE:_JVF_PL?NO M65O#Y3/$-:U+_Y^@7_!MS\*AXW_;VU3Q M#(B/%X*\-3W*[OX9;B1(4Q^'F5^N7_!2?]J&[_9 _8D\>>/M->T36M*LEAT@ MSH'B:\F=8H%/#OA_ M4/"G@+0[TZE)%?7"2WFL7(7;&\BI\L:1AGVH&;);<3P /RK/^&L9F/$$:DX? MN%R^\]K+5KYO0_5LAXCP67B(H9V/8*:^RJ\-9+2@ZD\/!))O;HCXJCQ)G- M6HJ=.O-MNRU/W-_8,_X*'?$36/\ @F+XX_:!^+BZ=KIT:XO;K2[/3[9--%Q: MVX6/9N^8;GFWC>0<>G%>$K_P=561C!_X43J(X_Z&Z+_Y%KZ8_P""AOP%T_\ M9S_X(G^-O 'AY7?3O"'A2"RC8+AIO+DC,DA'JS;F/N37\].X'N3D]:^#X7R# M*LX^L8FI3LN=J*3:2C96T1][Q1Q!FF4+#X:E4UY$Y-I.[OKN?KX__!U)8,0? M^%%ZEN'3'B^+_P"1:^E/@)X?^$O_ 7&_9FC\?\ Q!^#FG:3+/?W.G6DSWBS MZDBPD+YJ7<4<3@$D@*<@;:_GQ;CD'&*_1'_@E)_P6_T;]A#X"W'P]\9^#=&M4\->)+O7/ M!_C2YN;:UM=0C OM,FA192C2+A9HRA.'VJP*X.<@U\7#&*^EO^"G_P#P4GUK M_@I)\7=-U2?1V\,^%O#$$EMH>DFZ^T2(9&4RW$S!0IE<*HPHP@4#)Y)^:1G! M(&1WK[;AZ&.C@*:S%WJ]=ODG;JEN?$\23P,\=-YOZC_A7\-=,^#WPY\/>$]%B M-OH_AK3[?2[*,]1##&$7/OA!B_>;YFO);?>S[OPRRR?MJ MF-DO=2Y5ZO<_ S_@X%^*_P#PLW_@I9XDLD(S"K6;WD_N(=0N&MK"65%[".;< "96@5Y.G^VS=P] M*^Y/V _^"E/[27Q&^.'PG^$.F_$B]_L&]UBPTG;+8P2S1V,;J9$,Q7?CR8V7 M/7'>OF>.\DKX_"PE2DE&G>4K^GIZGU' >=X? 8B4:L6Y5+15O4_H- X/O4,T M1=PP)_\ K>E2J<]N#2L@*_2OY^UW/WZVA_/A_P %4/\ @E1X[^$'[:7B%?AO MX!\5^*?!WBQGU_31HNE37D>G-*Y,]LWE@A-DI)4'^%U]*\6T7_@EW^T?KP'V M;X*>/\$JO[W3Q",GH?WA7CU)Z5^V/_!:[]AB/]M3]C'45L+&.Y\8>!7?7M"; M;^\D*(1/;@]<2Q9&.[(GI7\[^F^(-2TU4-KJ>M6H7!"PW]Q%C XX##I^E?OG M".<8S,70_!^+,GP>7Y@W4A+DGJN5I>JU3ZGT99_\ M$4,/AW96I90_^F:Y9 MQ'D=#\Y^:OF73/V@?&_AUU:S\?\ C2Q93O4Q>(;E,$]3_K*W],_;N^+GA\ 6 MWQE\?P #R\#Q+._R]3U<]\5[M6EG;5X5:?\ X#+_ .29XM&>2_:HU/\ P)?_ M ")],Z?_ ,&[/[3FHW 6X\/>#;-2V"\_B*%P!ZX16./UKHM+_P"#8WX\ZQ$K M7.H_".P.#\MQJ=TY0YZ'9:,/?\:^;='_ ."J/[06E'%G\;_'9QC ;4/.QCZ@ MUU_AC_@KO^U-&4^Q?%/QCJ+;R%$EBEP7)'W<>5ZXR8H^/?]!5/]HS_ M (-]?BG^S%\'+KQ/X?\ B#JWC_6HKF*WMO#WA7P[>)<7&[K(TQO<11QJ&)/E MOR% &6 'FTW_ 6H_:]\':7;SZAXMU*TM9\QP7&H^&(8TG8HWFO>)KNSCM))$1K;3=$L$;$D[QH=J1AV)8]7=@!G@# MBIX?/XOV^.Q%-4HZMJ*=TNG3?U.R>+R.2]A@\/4=66B5W?7YL/@7_P $G/CU M\=_C5IW@^;P!XJ\'_P!H2&2^US7=-EBL=,AR#),\C8$C_,-L8;=(QQP-S+_0 M/^QQ^QQX-_8C^!VE>!_!=K)'8V@\^]O)\-=ZM=E0)+J=AUD;:.G"@!5 4 5D M?L#?L%^"?^"?_P %H/"/A.S2:[F"3:SK4L*I>:Y=!<&:4C) '(1,D(O [D^Y MJ@4 <"OS?BCBG$9I4]ES?NH[65K^=KOY=C]$X7X7H993]JU^]ENWK;R3T^8 MHZ4445\D?7'\B?BKQA;>)?&&KZHUU$6U/4+F])>1=S>;,\F3[_-_.J7]L6@_ MY>K?_OXO^-?U>G]EWX99S_PKOP)_X(+3_P"-TI_9>^&?;X>>!?\ P06G_P ; MK]?CXI4XI)8=Z?WO^ ?D,_"Z4Y.4L1J_[O\ P3^3]]8M>UU;CW\Q>/UK]Z_^ M#D]Z^T_^&7_ (9C MI\._ F?^P!:?_&ZZ_0O#]CX:TFWL--L[33["SC$5O;6T*Q10(.BHB@*JCT Q M7S_$W'+S7"?5(4^1-IO6][=-EU/?X:X'CE6*^LRJ<[M9:6MY[GF7[=7BC_A# M/V-/BIJHF2!K+PKJ+K([;50_9W R?J:_E;L=6M$LHE^U6X^0<>8.3CZ]*_KT MUC1K37],GLKZTMKVSN4,]?U@']E[X9C_ )IWX$_\$%I_\12Q M?LQ_#6&0.GP]\#(P(8,N@VH((.<_ZOZ5]9_Q%2%O]W?_ (%_P#Y->%EG?ZQ_ MY+_P3R__ ()8_LJM^QU^Q!X'\'7<#0:Z]H-4UL,NUQ?7 $DJ$>J;ECY_N=37 MT-(9Y-3U.RT^$RW'ARX0K!LIYK])R'Q'GAZ,*+A'$=Q< U^['_!*'_@D1H'_ M 3PT:YU[6;^V\5?%+7;86]]JL<16VTVW)#&TLPW(CW ;Y& :0J#A0 H^P_# M/A?3O".C0:=I6GV.E:?:C;#:V<"P0PCKA44!1^ K16,* ,#@8&!BO@N(N-\7 MFD'0@O9TWNEJWZO]#[WAW@K"99)5I/GJ=^B]$<[\4?A?I7Q=^'.O>%=;C:;1 M_$>GS:;>1K@,T4J%&P3GG!XZ\XK^9K]NC]@CQW_P3]^*-QH?B[3[F709;AXM M$\2)"18:U%DE"LG*K-LQOB8[@+LN+2\MUG@G'7#(P*D9]0:X>&>*:^3U&X1YH2W7ZKS.SB7ABAF].*D^6<= MG^GH?R0Q.)$R"#]*>,["/TK^D/Q]_P $6_V9_B%J!N+KX3Z'8REBQ.ERRV"N M3R25B<#]*Y:/_@@%^S$+TS'P'>NI)/E-K=UY?Y;\_K7Z93\3\N:]ZG-/T3_4 M_-9^&.8(5M/AYX5O- M3L5D\NYUFXS;:19=,F2Y8%20#G:FYO\ 9K]__A3_ ,$BOV=/@[>17>D?";PQ M-=P2>;'/J43:@Z-ZCSBP_2OHO2M,ATJSAM+:"*VM+>,1PPQ($CB1> JJ. , M8 XP*\G,?%&\7' TM>\G^B_S/6R[POM)2QM6Z[17ZO\ R/EO_@F!_P $M?"O M_!.+P#,8+O\ X27Q_P"(8D77-?>'RU< [A;6RF.:F1 #G\*5D#8X'%?E>+QE;%5I5\1+FE+=GZIA<'1PU*-"A'EBNB/Y8_VX M_P!G#Q%^R'^U)XP\'^)K*YLW35[NYTJZFC,<6K64DSO#/$2,,"C*&QG:P(., M5Y4&&.H./>OZR?B-\*/#7Q?\/G2?%?AW1?$NFD[A:ZI91740.,;@K@[6P>HY MYKQL_P#!)S]FZ4[G^"G@$$\X&G!1^AK]6P'B?3A1C3Q-%N25KIJS^_8_*LR\ M,IU:\JF&K)1;O9IZ?XYK[I_X-SOABGQ$_X*/1:RQ1X/ GAN]U8G(. MV:4I:1 _59IC]4K]>5_X)-_LW(Y(^"?@#/JVG!OYFO3?A#^S/X ^ (N%\$>" M?#/A3[8BQ7#:9I\=N\Z*255V498 DD ^IKGSOQ$H8S!5,+1I2BYJUVUI]QOD MGAW5P>-IXJM5C)1=[*_ZG?1_=7Z5)4^\&^-XVUW0KK4_!$%S/DL!=6S2%OG:.8ALX!V3 M1_4_O1(,FOEC_@KG^P_IG[G MS7S1^*'@G_@IYJO@O:1\%OV;[]EYW3>!(XR7[-\DHY[8Z>U>DZ/_ ,%U?$N@ M!#;_ #_ &;8$3IY/AF>-N>N#YW&?T]Z\+\.?#3]G/5;2.6_^+WQ*LG:,,Z+ MX!B8!CU /VO/'N*]"\-_ G]CB=P=1^/'Q1C!==[]?7]*_9\3A, MIEK4P\WZ*;_)GXUA,7FL7RTZ\%ZN'ZH][\%?\')VL>&6'VC]GOX8S(G!&G:G M)IYVX^5>;:7'ZCZ5VD7_ =/ZE':S"/]GK2K:8QDQ2)XY,BB4# +)_9J';ZX M;/;CK7R=XE^!7['=L?\ B7?'KXGN-S8'_"%K+@=N3(G_ -?VK'^''[)OP=^/ M/Q-T?P9X ^)/Q/\ $OBCQ"_DV-K_ ,('%&K, 2[NWVOY(T0%F;& I#/<]@U2A6@V^BY6_E8[ZR_;M^._P#P5(_:"T#PI)X! M^#OC[Q/>22KIL.J^$$NK?1;9FW2.\KLS1V\8(W2$%CA>K, ?VQ_8F_8F\*_L M:_"Z+3-&TWPZGB/4HHG\1:QI6C1:6FM7* _.($+"*)2S"./2C'HK^\^[7Y+YGZ5PYDU?#T_K&/ESUI=[:>2_5@ M@Q]32T45\J?5!1110 W91LIU% ";!1M&,4M% ";,_2C8*6B@!-@HVBEHH .E M-\O/7FG44 (!BC9S2T46%80( *-HQBEHI)6V&-,?''%+LXZFEHI@%(1D4M%* MP";!2@8HHI@)L&:-N*6B@ HHHH ;Y?3GI0(^:=10 FP4%.:6B@! ,4M%% !B MHGM@7W D$>E2TC=#0!^!G_!5O_@D=\0/!/[:6NZC\+O OB'Q/X1\=RR:[;C2 M;/S(=*N97+7%LQ!VJ/-)=>0-KX XKPBT_P""2W[3-_;K+%\&/&!4]-QM8V_$ M-,"/RK]KO^"RO[!%I^W=^QMJNF0Z78ZAXR\)DZWX=DFMDED,\:GS+=2P) FC MW+@?Q;#VK^<_P-\/KKQKXFTS0?#VCW%]K>MW26EE86L9$US.YVK&%'\6Y]QPGPE0P*6+J1:J- M:)N_+\[+4580K9R?I3Z**^%/NPHHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@""Y'S)VPW6ODK]D+_@GG\,O@/\ M@?&?XG:)I4S^*-6UQH[=KEDD@T5+B"* MXN%M$"#RO-DE8L26;&%!5/EHHKTLNJSC1KQBVDXJ_G[RW/+QU.$JM%R2;3=O B+3H?6T4(B<8STJ53D445YAZG86BBBF 4444 %%%% '__V0$! end XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover Page
Apr. 25, 2023
Cover [Abstract]  
Entity Central Index Key 0000105770
Document Type 8-K/A
Document Period End Date Apr. 25, 2023
Entity Registrant Name WEST PHARMACEUTICAL SERVICES, INC.
Entity Incorporation, State or Country Code PA
Entity File Number 1-8036
Entity Tax Identification Number 23-1210010
Entity Address, Address Line One 530 Herman O. West Drive
Entity Address, City or Town Exton
Entity Address, State or Province PA
Entity Address, Postal Zip Code 19341-1147
City Area Code 610
Local Phone Number 594-2900
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.25 per share
Trading Symbol WST
Security Exchange Name NYSE
Entity Emerging Growth Company false
Amendment Flag false
XML 7 wst-20230425_htm.xml IDEA: XBRL DOCUMENT 0000105770 2023-04-25 2023-04-25 0000105770 false 530 Herman O. West Drive Exton PA 8-K/A 2023-04-25 WEST PHARMACEUTICAL SERVICES, INC. PA 1-8036 23-1210010 530 Herman O. West Drive Exton PA 19341-1147 610 594-2900 false false false false Common Stock, par value $0.25 per share WST NYSE false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.westpharma.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports wst-20230425.htm wst-20230425.xsd wst-20230425_lab.xml wst-20230425_pre.xml wst-20230425_g1.jpg http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "wst-20230425.htm": { "nsprefix": "wst", "nsuri": "http://www.westpharma.com/20230425", "dts": { "inline": { "local": [ "wst-20230425.htm" ] }, "schema": { "local": [ "wst-20230425.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "wst-20230425_lab.xml" ] }, "presentationLink": { "local": [ "wst-20230425_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 5, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 25 }, "report": { "R1": { "role": "http://www.westpharma.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "wst-20230425.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "wst-20230425.htm", "first": true, "unique": true } } }, "tag": { "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0000105770-23-000054-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000105770-23-000054-xbrl.zip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

HG'F3U=B8 \1H24XW1_C$HKJAG M:W:#ZSM&7)TTI5$JZ[658+ SS9!$*E8FDA75/BM*"@9N.ZIWT9)6,KZR*(W* M>"RL^N.AFR^,(DH7Z M;29P!76#?'V!EP@9S6ZP7]2E"9DS>)ZB:PIBA?$#[4Y\T#;TL;[#=S4I?:GE MY&.7,D1.+D@T<]8\*%:S3$ZH/E!Z()C,4T^PJ*R4JZZ#^HVP9 M_6G^1PX$<(\\LT(0 MX',91Z@/RL1V^>02"*23RTTKICV/W=Y?D1U9G4,H?G@8E_/*1V A3#T=E3RW MZ.SPHM?HUU #$TCUVUY#74(_0D*?/=+EA\YG:--R0[I88B>!+$G?V,6]<;DP MLHATV CJ31O 8R'Y#R9I-\GNKUJO&L()X_(RDD9>RU=I)F/C)JV_UKW?L/@# MBX1#_^QS$7)D#,X*,(%#K-[ DF]>)U\HV1L-B*I_T POWG\/RK <=:%_1GE0 MP0>#2,60R!O5D9 E_7_8R6=/A=@3[.(\*!-K]S_V>!9/O2SX(-T4M9 B"(DS29H MWK/%=PQV>R"O&YQBS[A]6Q2O6Q$>+D&A]KSNWFP^&)OWH\F<),=1#6;AK3BV M]F;=-PV7C'\$U,"R>BIJ-;ZE;I3LO=B>$71B B2X'ZBTV.XWOMB.XT/HD@;: MO?%T\SLO]VZ-G'8*\96]>KM+6LG.]*09\>1 >!VF&S<93&D&XZCN8);5"$,. M? 5&WQA4E>W\;>,M(GO[&G7<51N8__XDT&61PS_M5-"CAY7>$U\G[S[]Z1BV MGP.1)#^4S):<>"!,2;+:&<5]7BBOW1C^^&#[T@6NT51[/^(EJ2@N>?OU+OR8 M/=2/A4/CV%?$5G2%7SS"23XDJR/GU+E#,7]EB*/8#RP\1)-L M_9(@E9#6.,B1$,5.)C#>)#V89E=3=5=SYG+^>/?$PUOM:8I%F_ _FVLV16#! M7?H[AK27K.[P@Y&&N]]"PGY3[7Z&W!)['O/%X8[(#:"3WH!ZAD6#BPKM>/*3 M+E<%J=LI%==QL'2W X&(RA(=N:/2HD?J_\:R% YC>[@7\)3H_+OSU3#N6*\T M.UP6U<("\MDB) \]\?PR0EP@X?$.)$9_/CW+0YVB\O-?F,BU9W%9;TZ]TZHK M(TIJ)70\0=[P)OK?T1__^>OUD1G8P0_*\3YW%55%Q_H*>$8;*SGN06?+:^#? MI_.,N4CGPY[](!O3W=((RN_6O3]-G?N]?_FQY;7)?HWQ$* M7^_V!Q0R!B!'JJF]M>^>%V=1I[TLRA:2>WO.QX_%.TS$J%A;R'\JE+B-%O=2UA[=T%E(G-GY;R+^#X>\.1&+=U"<, MG!,X6=4<_?SAVH5M0W;M[QQ!U-\@5^TN9G(KGM\^#9]ZH34O;ZQ1@3MV<]Y' M$/SMG=BOI>+T4?&Z*>+,+SYU;-'K/%3+Q:;C=[JC5BF70)F JI>&Q5,[OXV" MQ>G>?Q&LYL,9#E["/[B(*S=OF;C<_>#7 .\'(KNL3V[@0;BR>1OZ.]>:>9"2 M.+Q&X=_LL3M\VJJZ[%/J$DQ@U;X M&(<]:0>7?E]E%XD5]]Y>W_F[%^5+=@) M6G<#&X@\[ZH1"E%>+'"<2479W>65#9G?&,Y%.:*^G$-<8,TZ")[,@V;BRC$O MUDZ/WVY\M_S#<&=@?"QI.W9759G!;PE"9>."OL)(% MU4;-;XB<:Y'S9#6"5BC)?&#=D[HB*\1* M51%D]UY14Z=R=L#ATP,TA5+-=6CPANZT40)B! 'CA8.VR'UDR5[A_;HL/V\K M)J" ^KRO0#:A=))\H/%L:6TVN(] ;L XA 2-.:8PLA&\J09RA4OR#H:1^Y'/W4YEW1 MV?>I;#T\IS4MWR%9K?=E#2L5%)F !W0BKL58@*R*CMW%O3JX.__OYVWTQ $' M0U&RNL5$8C[8PTVGQ#7SCW: MGG ).;KS/""D!-D;2(G"IO3*/4W^KB$S?%J'__\KL52 MK7VP2YA6ED*[FV;)X)^NW]*5Z^[%$Q,.^Y"?0,1,6O%4O=8YP^1;B^/V/)IYR M6S^=)FI .*$P[NBTG+8B]5;#78K%:,/'NN7'=C9YVM+/M'6@SD(_U'WS=:A^ MQE*1.:QRX]@EP6DJZE,%>+7W-GU62<(3]9AON9O0+V.KP33I?*IY%VF HC]D M#)GJ(Z_@A'=]$K^%C3N(9#X)CT]ZS *CQP?VBS#:L?H6%K1FL RU;I*-S/YI M>7=%D3'1W(PL=8*0X-!)U28#5,OEW=+3$@W]ROB1/*1,]8U@I? MLV$"SEW&:-W,649]>UT(-.I]*!I70/2K.W ND-J5E<3<1-BZ_VI:1_&@Q=(4 M?0&.L2\T3U '>[1)A':V,=MR)4=O4 UAKF$H6ON\-FI<<..M%FK*8?['\&2>LDX!(?PRG]IX8N&VWG6<*0=+092A9AOU%:)?8'VR%5L<+8]4 M8=A Y:N#JL* 3X)@+.,#+1!N']-9MR#B'S!C>0L9XPEBF_<1IP^!W.,_'G]T M;833.!!W[IR*DNA";:_"!Q=IPAX=DJ@U.BNJKT!OPG7;5_H>T0@!^H^PP)>" M;N_PY)3A17:<;#4-YZ49^DSKG'2)6AMD(P5>@R;98&)[J;JL^'$UR8*6(VG* M3$!FZ4 QRLUTY:1.;Z _,N>V6L%T5RD"+8O/4<6?"Z &07F\]]'VS7H?\&ZQ MG4:Y F,FY.@.AOZPL1(XY4 V*S^9;D=6I1V4$M/D)3R2\^YIC8LU_T?3/7[. M$?4N='J>L^A1U"N6%(_>I'E@EB?54A[OA955!_-GWP=6C=I_RR5 Q>XI;ZYS MWUZOT!T7X5_HQ$&]P(315NZQ%W*@FV];U;S[,3^)9=3:+8) M.<("5@IY:Y]2LG_VK((\4Y\6&M4I#O0D8SGDQ(SN3Q(3:$OBMRJ;&;^LYN>N M62(VJE'>*N&..)MV8O:)]6CS"6&71R'28YM,@";53SHUAH?2A.M-Q_HTF( G M[:]RX+C)##R\&=R$M[\-6%K\KJ<1=/PUY9> M1;1\0.&!ZRGOK6&^3\_'//@6M,G[X89V)QUO-:ZONB7%/%G1DV[]*L6_>;S1 MF.B'#VZOWWR)$Z9=(/)IVMM"78V]]_85K'1Q\Q"JCST_%C\=S,C MA^Z;!\GP*C3I";JC%\.&[$+S(&5,%-,5XZI-ZYHFQ]4Y7U=DYZ&>]JN8,P#E M.3VB0J((L>@4D$X M"-@ZY^RM/SQQQT0L^GHM+Z+XSJ5E:2]_@Y1W3RRT6PU$[[_5O&0X*.&:%YBS M(WY!8A821I=\S?W4\]OMU"]5=TN0 2X-JR-!7@8U&Q,;V H_FK ?47V]]O., M%TZ@0=ZORNG,-8%"W-TN=T_YW$VSI)-2$X&__P3\27:&KRM354)6*<9@&D*! M+& 2+N"HLQK,??3=H[+/#]V%S$^]*ZE_GW3#7/M@@%7NMJR64HZ _$4]'#B* M.$FVW4UJPPF#CL(>["M"'']W2X>T0GLN[-\R4PF6>QNX9R%CE,3@AK&.>U[! M.O # D;JBLL#TP/QSZ\+F.F'EXB%7;$?G%;^Y:X5^M6T^T0AP!OP\>/8PE^B MLXNP=BKO;]G?"=/9V3@/9"W4/)KSOD:HL_=\Y6)IKM?*C->T"LJXKNMF\RXF MD'5NUY!)*GZ3)F(R.Y-;4)_?%I(STU/S4>)DW31'T[1.O8-T]T\+J?K8BUU(0%57BT M0DC^ZIW/_=[@2+=P@LM%P4?C6G[ZI+UY\0NK_$KKJ@9CIV&/T'3.C%?_WJXV M_2)R)(<-#""MSJ:W"[S1KXUHD DO7#HPFBDR&OF=["=?^>MMY:'?W1;R+S2O MH]2_#RAT/GCO:@'[,'X?[K7_SF9@/ MOMMT&5;=..EP/\T@Y*JM^^,HF_/?7PJ4AONZ)20*\QG>WKUQG=[5/1]RQI5\ MH\TDM#Y\\3<38$>(H260.J!NZSD83R_!QW?@.G#LGY5F\0-^V"]K[X.VH:?@ MTW!-*8.G5TO7Y>ZXVBZ]^2:B/@N4P:[0/S;)@'";VN&=S4,A!C!L58!JXTA- MDI_('^Q#N]L<$'_O5NQL(:M-H 10+?I-0GGDTJ8?9'9XS%C; =O;I/.)?/^H MH58A S8CXZ^EYY):*M>V:@5='_UIN^59G(=Y7NL3]@P:UJUI:6@45>PD?//\ MVE2MZ5^R-HNXYV)K4#%,X*'ZJX4Q_$ $XA*9G:#3D"2;ZO[UCD40_T>-I.II M$:XC>0E%(P,R;'(D3 ?TN_FZ*1G3Y8B-"<*^AHMHHX^!+TG37KICD[?C%(8W M1WIUSGT"#AO;VMH>!]CFH")(;;">J-B>[=;!.#VVR])@QT)>+F/4?1E_2)M/ M0F[;GCBEA+_M_XEMLO(I+@YYXL^A\)2.F9,52NU%20XY1GF[<@(SV&MXAGCI M^\'JHR:35@0?';IH7A54>P#,2?1VVAM$RS^SR-\.,X(]_\ORZ"VT:J9 =HG! M'Y)_>Y'N^5*NJU)/>W )2S))FHQSC/,'O14*?O&K!5D]&C!JVE^>:4*5TS%- MLJQ]$&#LFQ;T,@\HJ%BQ@)C#!I MD28R1?F:<_' KYT)Q$S&L /R?OY876O#2K37#I8'U6*%\G6PE?L^C#SM=;;- MM1)4&:A_M)CB%T\LZ@\9CPF0=%GW@@;286X"_+*^&Z\?!J=!28\%.NOWWS22 M/5I#1(@JI^L_H)V3*A/1CDM/<:"V5$=M"=8/S"51)DRD0UV.9ZZRCV78?*0; M5R?,8D$E+IJ(V1.,#QXCN;*$:[@9.'M.;Y/&T[7JDHQG E-H!K=IX=DN\5;1 MU#:.;37#$Z<,YQ(K"YLQ/**QA//KNYE0A/U"^&'^J$L_VT:H^0=:OU&/X*!. M2A<3.(3D0/^78V:**"]" MM9R#/MKD3WU/DR&O"9G$Y*9)R:P+VKQM+H*>TS,,G&EB*8"7+QECZ)JHSU29 MU0<"N5_I M CI'+6X?98F-1XDC&_!)16H^_ W,LP][K(Y78<+]#[@WEK<@90BH1T9*A5]B")LE,M6S>3& MS[4=J#/>>27'[44"K%H&@EI&]Q?0Q)SL)<=HHN)$D5CA/--DA_Y%<^$)!+4KM[ M67E?;E^.Q,NP[RO&;D+[J)&,(^:$56@D5A:I2+LVG"MPGX1KULW,>C>%?)8L M*EY@UR)*]HA!V(<3L4(K892"D^A;HQOSPVJX>BOE=+^1A+#@5FPLCE2"\[M+-J:T^UERY047%1UOE=T M*7V_QC.I@PF4WVCM>C0#&\%N7:6.,?C&Z3E8O!]C1H"056=W'8JO23M(6^"( M"+IPK@4D]OF!?*$#-''Q]L5V'.DV+*8A[:ZQE8'@ $2AZ@'#%)N-S&)QS#HF M4%D'WJ3R]1*H;YYY086J[;&\]GR4JSPFP)Z$T'0LWF-RD8J[%6*Y+F MWJ3HSPI9!87S0OJM4#/=U7^P-X79(WI;F$8X^<=N1B?/BK-V]-?1 M:H4^QJ)?:]=KKYL2/O(7+P1-[/R[B,&RT&D6%<_>#I%I.D[3J7FO@R9A6FK( M^DJ PC3A\I!TY,"&SWJ4 "P+$C+6ACST=W84>0H,&YUOMQMS+"T)O+!4GO%6 M@U9Y-WT]CEP!G]2E%(,11/N'&F"D4XY3P+L WQ*WUX%+:EOWY*SDLL"C7[ E[Y M %693A/>:&L_2*VK'6F2ZYM1JG]2]Z!JHF8$5ONNOHL>9%Q-)(\^(F4XYW)M MWMZS'T"U;1LA.7J-JS,ZG[BL0T-I-318GP"HANG,):P RZ ML>"JZOW(^A7OI8J/IUIGB^Z/3<3"H[ QVQFC9P@!U=[8ZM-2Y=TK%T1WX&UH M4!F^+DY"X2DQ>#@?XEK34(,!OO[(^6F=WT;Z/6FC,\=;S2(RA;JX/SUX9ZT) MTYZ'5L+6]LN0(W!9PPLD:IN?IVPEP2GJY5&U.)5CZV;/@L\>G3R4\V+LWW46 MZ/?0 J_CR/8('6X8C3:-(F=N!S8@8=8W0?5%5P(LIK *(>PS@9\I+8/KGBF/]NVHK7/_4UC^C%\F^%0*5L]FH, MMWTI,K:6)J5*[@EA92$6CX'L[ 8Q@_.$/ MGGA#Y+"K=>!;/O]-@L/>_@^$/X4^0]%NHB-@U;*S,\4S=Y10YX)T3\U9*[P"D+6JTAZ)^9] MS^)M1"=8F5-OGX]05?+V7EYWMSA97Q,H3;)\K1#Q'I_Z!_\^'X M-8315S$O*[)+\>=]:_<4 LGF*?F8)P.B6"FGX\%D]#). "VK?B/\*#/E/5J4=8H-1]8-ZNSII(')S^[,D0:OBI MS.NB.#3O]M7@'4"](I!6V\,XM_%QNXJ;?J.BT:F=/U_B^&$[LW]E1[I/[!WO M6H1W5R47YSY@3^Z6.Y&T35L]@+"0BXOF.8S40K7HTE0R\]MKTY%"/W^05OI/ MJO3SU;N*RN].29UE7_J"%2>6";7=.],E%>E<5*^WL^5-2YH Q>,TCN_W]IQ%E]SH&1C" MYK1+VZ\FT63.D._I@1:S>G!(0R-9=(AKT<]JC["<',FGL;:8&?'8*]PDU QI&H(Y5%4 MOYQEY1_5CP5290J>"RV[AXX'KIDB[US5_$111.USKE2']ZQRX MI7"Z@>NP;)Z;-LB29IQ?Q[31$[D4ZM@&S92TAP]./,\$CIN(57Y909X:5/,M MXZLHC"D-YOE4?]_?3/0BG2#S*0<5+,-V67E.'51)7U,H0$[!*_(*?9TLR>(O M\L-1%L,G__:OK<1)\12[O]'4BOFR]#GJ0:+<[TG:\]=:DGJ&K?P_&Q0V&AVK MUSV^8DD"XR$%;/:B$>\^K>NM5#72JG^ M?@D4$DM!C]FET+QI&?Y.5RZ]8"T M_NN=@-_N.B-<>8AVAF7UNZ$&U3V4.VRB([WWMJSUN^XGC0)]F$X#9#6Q210\ M0S7R%NPX74"]!*:UG);JQ$55:O DY#*V<3R>P7L% (Q:>)YIX49T#QG1%YXB\H/ M=H30A,0I#X=\1GP8O"&RX3%5$J4)+5WR0@Y)BF,S#9;;^/;&7T%-.\]%SI!Y MD'1'5J]/34I&S>:A27=QKQB*H-&792; ?UZ=$^&:LW=;\=90@U.^<_B[3OF8 M7]:%O]C>=E_&&/'8-\NR5.++]\LSZL)0FI;?VE^/!8Y>]2@%?VXR$S!Z8?P! MX_???IH6_6TU:M+\UF 5!-)+JF<(==S;CF ME[?6.T+3UUZS MU'\EN?(H.,/OZM\L!3K5J?OT.87= 7J)X%H$\TYEZU6+M MA\_!=+;Z&BQ@T=P-#UH(YP4/X$:^)W/!"+4&=K]R%YTQ=XKU(.D2'U8A*%4?E?!HX/; M;L^_'WZ^WRWKWM=/>_)#0IY^&#C4R$75@6XHKL(_!!Q^5LEKNE3F&#"D;+\= M_+QRIR].(41%/R&X_^;&#EQ5W&3?E5X3]' ,Y8.)'[M>'PAN.UL[!1C?I9%9 M7?R%0('EME8*I/$9NJIZ+:QV_1+9C'+JJ]2 -/AR7B+P9857K;4&*+O;J0ZS M9"3VNA)?Y8OGYT*Z&4_[2WXU4Y!7>Q M(BMV!SKH!IDXH_9B(2VW[&].@6Z@;9)7[PGBJ:8-EA9]AO7P YV90"TAY.O" MR=/II'K+%+OD#,VO6[/5C=^HTN'Y7?3 $JV2EGO^V@$PZ]L,!CJFR30BY%^0 M"M1LA*[KL5';@GN="6-![FN&),DW@J?C2XB-=>W0X_8/V[PWOG3FOP'$3@9K M-/?([V'F4XB8-S@6GY=I"/S6;6*<2U"]3#RQZ.^=<0YUEE%L&%XD(!"B>*>) MXV1%>0XQ^.OXA\4=S%S.S.ZNJ'>&O_N/TQXMC-,&22O>VQ">>_/VPHZ.V*#P M=70^^%FI,U$VWC8-^VF1(U$_J7GH3*OKQPL'A.0H9-ZN-I7;G#BV%":P5D U MO,L8A50E12)E'+G8.\+>/TNWSOW@/J'K':H$"*0['L@Y$.#/LX\ M_,Z2-":,V.,7H"J58^A5F%'U20S^/8N2,0%WS!N&0(V!;X,]/L'JZANB7NCZ M@QB4G2CH(;M0CLGZVP:?SO<^J,FBJ2!7FQVB]IGOH7^ZIWRLK M7HH"1[Y<[>1R!U"66;5_AG5L+ (Y_$Z=OR7".?@^*@$;;-?HLT@2[T07PA7+RY(O M*5#2S2D6]6-1ST:4TTB# 8H $P QUY)@C5&MMQ,W1G)3^A+OM.'AQ6=NF=\( M[%1F*:F7E:B6^V78V2]ASQ+P,'X0=8-4\*+*X&^1A>ANJU5HB?/K*:GNHJW. MY*CP0HD*IP!# 'IV /26^$#F\+*&U#DW;4_VVC7YF>P^CGY#<@@6^'4,O9F] M]G-Z"?W/&DMB+=VZ#FI!=Y;(!)[04#1;/A:!%4#^C62X&?/WL"!.9,<#"NXB M+MK[U8H.T<1 ;0QR$"5F:##KQ^.D/8,E9'645UT3*D_IO3KS)E9BG,+MO?:- M-&IER9]'(EF:V9_0[QF;K;_O4J\+^X<:U&-PR9.$[_WV]"A(I$6#= MSV<_GWK'396J#W6>#3_D-*^:%^LL M&,^-;?^MDYV;V\5$XA&19W\;E\<46?=F%^9-6NK8#4*>=TA?RG3G$8C*MW&Y M,C=IO7&P@6R"TF0L[K6SY@M+P_^556?UJ&3O9=B+' AHQ>((G?2,7!9XMT,B M,Y^EJ.SMZ0?E#814KES]_K;)ZVZ'M#6;_(N"$SZ8Q8ZZ.6E7[!74['LTR8DN M13D&\@20]CJ1?&/:TYJC!T[KFBR SU2_@"#PM*G<$I$^U^W?95">>&%':X.[ MX'7;V0F%"V>+2O,V?6OJ]?10"6==R<9=%S[>/9U#ML-:1Z-99,T5.ON> B59 M"PB&>-\FC<6H[0YP@4,+"Y.C8S?B>=8U']UT5QI2$WOT2SAZLH1[=O'$6$?; M<4P^=K: Q?!NA7LSN"W(P=='% >GVHS%2.U"3H_"+'Y2K[QYX*[Y[UK+Y0SG ML_%*K9SLBN^0GA(M)QX$8VKP2VZY+[Y6BH<2V$% M?CJ8P82W>3[!*%G9^_"]-C)A1)HUZ=KYG3T]F]2 )M">- M70.-2(MM,\*#KCH'T*@J:KC:+ZUA$][[XL:@,QHQUAJ"SKA\WG/6E;ZPG[GE M%+Y&Q?)6]%"]/DRH!ZG9KNQ!V:&SL_!8EM>5J-G\'/D*\Z3L[ZA<*K8N^4>?M?=3=.2V!!^#7 M/:8G2K=$-D.XQ6>#URQ(!:TH:$9NB$OKA5K@:.HG^Y0"ZN-_8ULX_9A32LV: M=9._0O\9*6_ Q@48W#94"X09B">A\?Q9Y%-[U,-[=[X//>MUXZ@T=Y,J2N;M M"";V)*0;!21N68(T%05+"[/L>>6#L##TS>;0&0C;F_=>'3]N5]DVPI;. M\PLTFIPW_7=.D0F4+M\J&O#E4SZAO(-97 ^&(FNBM_&LM+[!JJC;(9MXKO5\ M@BCH-PL1!0M:9E0\QG8&ORS;N)@7G"^[1NF??RG\("^5"[P;KMQ1!0<5<.L0 M#!O%[V4.M.4LMO%ONYSB9SK>QF M4A>/+![OZU*W%$XR,E#L%Z-+>5D%S?^A0>(T$;+P#[JWA.9RBE/S5ZIA13ON M:)I@&^7SL)J=!LF[/3F-8S-MH?]8."R[17MX"4>ZA)I,<;G1AI].+7(78&24 M.;2'R@C\1GKMIU^C?T+XL61!):NH$U0WKXN(AZLC"=5<9S&83!'"M*X3 3:$YG J?" MM?Z[,+\>6K60ZR]&;)OAJ[PUK@Y]\]F?JTSP#G&W+(Z%(Y%N2,-5067G%>B1 M-7Z!WH"BZ0LF.='NN0*HSB:?0=9YOT&KQ-X'>)"Q71['FWU,?G<:?QJ#LT2, M,G;]N@2L'&%#3OPRU7U3(=997#[\7ZC+1T)#YK!>VICM:B6$JC(@@(&$43*[(CE]UG?5.-_'O\AEXC;$851XEGFA"//,/K@ M7&H-,%8VO-&O3=HM+'.MK2'MO488A*2+2_WL_BOUSU3:ZWC*//;D18E[7%G7 M65E32,<@9/*G!@I#:F]55:,U6@(*0=?C0\^DWY8,OF@/[O!_-AG=Q5)T ^ON M7Y>#PQ(6&@G>]7KK\LF"I5730BU20M;DSY/)T:YW=H/O'0YAC\V!0.,HX)JI MMJ5^S9?LH>6_*)N*D(9$J_%[I%T9AT>IT[O[WT%Q%O?]".Z2<42[[-G]!C8" MAHL)/+KZH(F%K#IW2IYV/^%-,4R(D*.U/;Y?>[5+FJ\/^P>Z%D"5#M&ER($R M^2&0EF<5YFZ/#*E3/:2QL.J)&_(_LZ,=I!XMM[X0O7B#\P&R&?<=_A(URP)9 MSD^DI%=K0]X_7EXO6;W56A1:=I>S)?.6YD7I5]?>QC5OP'Y\XP38FC']8&YL M@$0^S+V?6KCN[KT_N3D_3A=^#;I$.< FJZD3OC,U6S#8A]Q\D9MP^? 6@Q8 MW"DVHT".PGS3'C:M-KJ\L).>'*R;I=63LKF-TL^GES^"SJ_@& QU<&PW#.6. MBW(8H"EC#Z%F7[*:7L(0>N(Y'NT7GZ'[]4X[T%6I9_1EXU6UZ&@.Q.(-6W]KB#965RF+W#BQ5!A[Z%O210TXM/W?DVUGQ9&3L&2=K-&] MVNOI-CA\&5>B;>Q!W[? >@=/[]"-T/3U$4(2: )U@\5F%F:<\%;G7E&K,/"Y M#?7PUT1^Q:;6RS@.JGR!5SLEO0U8X+-P+%I?^_C\1*;,6(8S/[:Q<&EH,]-ST M:;JV2B@3#FU?[IU\HJ3L$\[PV'H55*S!!-3MF,#>+JHS([#,H8M==])GZI&B M[+T>BNPN_1Z$%686U\@,GH71CCFBR"+ER#X4W_VW^@@CDN:YDY%JD5Y'3BQ" M5QBINVBRZ$F__R[?CT U&U\/NTV]$XK'A^=*WE^--E"CI3%X+G *@,D&=8"BVTZ >:3<*;U8TV0 MD*A0;2/K7MBKW@!\;[3"O/&M^!Z6R(E M36]=$#FYE MQ>^MG=[>FDR3BKVKF::^4^ MKD_"12MLSSV68"7-(EBSD0;+@M8?,J8ZX"+54_?]PK]U"3KYZ/Q[VSG4 MIWO*J-DO^84G=^1K0(DJT&8L_K=!+O=2@:=C>&)JP63"]\F)YN\F1U9?F[*9 MSRJ;NG$#S;/W[KDV\;RIPXEG7OKSDO)T9MD+5TP7:,3/<+>ZO[/-VU\)7FH4 M_$V["<+S$7?!0$R(O5/"UT&:>4'_UQFS.MY!R]=2'(L?9?6W8QD/L;Y)XW)= M*!(,%ZLK"8FKHF8\E?"5515NCSDJ)CGLH,#=\ZMD2J/IM$'$;\TZQ8.8H.[5 MT4H$#'\7VG$@TYGU;?S.RL\@PEI=54.MP^S'H#:Y0WD>PY)X?,X93,JPK^#" MJUKXMVT#O?0HI8<[A+Q]#QGT\A)*7D,O6?,(U#+D=RO4DO&6]M]UUT[T#,9) MK\.$5;QQM-L9U_;E)[WWRF#RJ3'-=.6T),813JH&SU\-DLQJD?S^]=+I4%0: MC5%]X X5WEIH7 F$#4*'::/(XPO2,_-7IQ89YML=YWM]7V*=^ZXX'6QM!6?%3GF)W-1_\N'?[+?^SKPM,X"$6Q1!A M0=@IK *"^;?2XOI5J825EMUIE MO\($NO?]&$?_2XMJ$H8F'->L=5R-"> 56'3@C:OIF/9>=*\]L"$VVM,3.VW- M?U1E35=CJ7CW6H%;69A;9L8Q=G1KZEL=/6G[^9 &]\>VGO;M5IFWIM'?[OL_ M]1_.O?PJU/6GW+X;O8ZE5 0$D=VH:L5X0PC!6SE+][K+QJ+ESTPM:2!)=V(CA.O=3#"\ M+C:76I992:5 S_8U:&8[;A5%E;QW:LP,"^_:UJV3)692"QA\OT%7M"!T-G?0 M6^7F+$DQ:C/(]0G_1/X9SV-0VTRW74MZ*!R4QZW]2[P**L[R'M1\E-K/W,&] M@E9"7Q@#<:])YB\16GA8S:D._\F':)GZW[$6ML]NI@'O+AI__;&-%51R.V=[ MKLK34LUKS,=S3VHN1V:DA>A)*+:-?W]W#7.0O8,*0J8JF$.X/^V**B!O)(UT MJQ^5NJIW(I8FQ8+/>M!LE<)!QZB7/!UXC>/<;) BADS=_5-6#>6X%&ALQ1;T M>$AL?_+"F\>S,BGFN]!&(=[,?3<&]R)58!E="UG[7.AYJ[KC:R/> E6[X]UK M=2GPZ;LK"0O-;QR"0P?%KM>_4/V^>Q-NWCJ1;7C:V!CG^&3($9ORMY(.^TA M_/RJSJE^/__JJGA!/V(0_#R+!L\L%,\VYB'$Z%F;$Z'3NA%R\>EK./G47-92!"&L/G'H, & E;[C@OJAQA(Y.HME MF=*%@8"^QTW>_S#8:.+4.\!64(C3QOJ$,HMYI^,.;&KXWA+T&_#X^6(NL7L MS;&Q'_:5\?AMOZ#,]@>=,)]C= 2N*H^R:4,\LUHLP5.>O*L')\&>43/ M81SOBVF1?%9P.N<9<=[%)[]KQ3AUTI0E[6$K-R?[Y.@Y5<6>\0\Z3H7,=7^Y M<8Y'D>(ETU3WF$(L1603X!'P\NER)A 3W(6)V=#5X:*=]%;C\KT6PP3&*"6H M:$B%7PLN"2K\%,5B; 18.Q,0 G/;U>?&68#>RB7BU<>FMH'SWI>[PIE1_H*M M/S1(\]K+@""O&YE6S_:']E?"W@X$CFM;BGZ:6OKAM']GLP3KBTMD2;/;29,\ M%TEY.6R@ 7%3>,;B[/+WE:9C5L7A8A-93Q.WZK7,_8[+/7TEIN=2T@R9@HQG M44Z3,&O>I)^J6F9_$?HYI[30K3N*YR MG.MYZ\F3)VV^_$H-SSC.$/YLCN?<"T?\7]TLJ=0XOFC_GM];?^K/_!7.EW+U MPY=_&_NGVV:6;YOG_36A63[8VU7TT_*KH&,!>&^ZG2H589C-*NUFZ.W*H';F MK\8-S8P%+#%@6)QQ3#-CR=1M$I?E M90J]-_D]>Y8NJB!2V-1@_33+\^7,MF! MS,@1$7DVK8O! 6B1"$/2HNJ$^ (5P9=!E\R='>0;YW\(W?]#I?P(/\N_6U'O M%G_8?6"?XD?[EIIRG5EO=US*^7.B9/7,F*U'-PN4K?CL6?J$=WV#Q7J.+< , MYUUWV?S;:YUX-IN$D"]W:Y=E(DS\>5GW6O;%#A7'QGA_S1#=_6/[<_<)]_W9[L1[G&CA^^ M]1?6KGU=[IF9FI@M*1QS[GG6,9%ZL2++%XSG&,[6O3TD>4Y?=GID:$^LKKQ) M],6;[^39/P#VL;:D[EN?G:Q^ M<+YL]^R;+8+\F[3==TPPNJ0MZOI\6@Z#4?'1NKOU!S7J'TR7XO\CO/EA])W[ M)U/7_O'[J,/YGX&3;]O$1-WKBOL.9D5/W=;;EK,MVIDSB%=53Z'KT,%= X=.>FZI)1Z;E)#J&_,Q8M%=GUYK' M;GN2;OEI_:O[=.?3QRL/M;;$3,HUS]>UDH]VY>@\9GQI:?!$5]%G'Z<3[ MKO-9DJ7O3M!K_\33JN[]DLF[J4X+ M[RS7O-#*NT^*&Z^XT=[O6?YG\IU[%Q->F"R? IQ6CYUEMX]Y-C'9&FV M_#1_(YG TH]B8%&H@"I&(68!!42809)A+DC\T_6;F&(B.1* F") &8HA-HJ# M)HH:I9F/"*Z<3I+TSS?E/X+/M&?#2V?5C^].;HKB]LUH=']___I!Y)/767X] MPKY/1DOKDX7YPX;]/:FL41S'H^K3)]-94F=HW:+1'[^=7\H;/>60I+."I[(< M8):\F55OGF>2%Q7K.W%YC1;E3[ T@_(M0!@(>OTP4R>GKSQO3D>>3?17;;SR M_V]?/S4.&8]*BU&JK\O?[87.DTQ=%CPOSKG0$XN^\E8\WNIW)[-D>CO1R_=N M#O"6^QB74/X*IP/^\+XS9./^\-[I7- M$/KP@%>&Z0UY/J$^I&JHN?LT5&_HAT>\KVF1%7PRP+1X'F8%\J1\X]R^6@Q3 M.MJ23*MQ%JE[!:I^*'2J]#Q;KKGV$O7NQ+X:*YV,+[6\RY/B\<.#O.'IM?[, MIWK,M!\S;1!$@=) <:0A#C4!*4D4<,0,57)B9W!GZLZQF%G45]TS+U]?9]Y%]=%16 M6^4+*%]4:FIT.-KXM;W/ERAY+G=PO+ 8R$ZZ[:)_;:*[8+)P=6JRL=G>3Z,NY>4GUR-KA, M7X91)]$-&W=Y_F[]V$7X+)M.[])DWA7-QDR24/"(@1]2:35J!,1*^1!H9#2) M<4BDWU:CM2,. XO5@0DGH3:%W$FC&\X&DV=3&*O* M;+1Q%^55SLN=W,O'J<@FXS!BA D1 C*LW$(-.;!(, @(C5"H0X51ZZIWS?.Q MR7$!SINC:R_%=;IVZ[ S"8>N<=O%[R3 VE@[J6_=TV#2JPU@57?U!NZB^Y 6 MMB[^E,HLO\WR:F&]+'BAS[*[M,@?SS*EQYQ%$>&: 0],")1( [%$%'! 56"$ MHI+&;:788KQC$^@&^2>O0FUI]A;(O1)Z>_6VX7VWIO?,YH&5O@\BG=* M SV=DD,;_X.E#(=@5Q.)RV-=T\M[I>P\FE5^O^07>?8]L>&,%5+2#QD%IB,* M-#(:8E]R4 $C*HPB*A%SRROU QUI0EF 75' $K!K&FG@MVW^Z,_:,(FC V$= MTL5V-GKDB0;' R>([>%M9H8=]NXIX2+791^OK9?R;L:GV>Q.YU?EL5;^Q1C; M4B)JF-8^@M#8\I]R&@!C4@,6E"LA(J7]UI7_KL&.+358O"!7 'MSQ-XW#DEBK:D=$H6.YT/EC#:AKF:-%H_XYXXEK>YGBXP M_&)3TCA4,14RCL$@WP<:8@%QZ ?@QU)0@7'$P[!MMJ@=X=A2Q-.EMCE*S\+T M2ISMTT(]D;MS06]Z#IP G)EQ$OW6Z#LIO=[C8/+>&M"JIK<;N@OY+/NN\_=B M5N1<%BWFW9K]$U3I:6((K?>LG:< M8UL<%IW2$JLW!^LMT+KVE?74MFTK>Q,V3%?IRE6'EG(K$STZRGJ_ S>46X/; M[">WF_=N)U>[&Y\+CC%&P'40 ?4Y!L$-A2CT$59$!8:HCHWD7ZF%W$OOV*MK M_(OTBP=O% _4(AY#<^C6%NZG(;S,)HE,"IM,?K,%:9[PR=CWE4:4(,!"!$"C M2 #G$09%(A[CP^W%R8$&[T.%V4[(Q MZFYW)3?=#7=;LC&4M?N2S58=VKUR%SG7O#K39$P&/) 48AF$=DUF"!A#@2W3 M?<]#UPOLEG!)_]);JO9)!3VJ8D92,H54(HC$$8BH#B,*%6Q MD,2Q):X;YMB$^/+L< [6LV@[W=BH9;9M1]R7KV$:8F>JNA^RUC+1_XAUW>V/ M.6"M#:WQ>+7>NOL9R95]=*S"D/LZ]('10 "-M0%F. 4I)<)(A%A)DA.WB&K,0; >*(8QP$$9^[/LA9H");YM*9@BP$ F[[D5^I*@)0MGZ#D#M","2M2&@S6JUR;"KD#\F MD^4?DAE?*8UX#!&1 5!!&<2:2:!:Q%)C$0J_]==3O'1^I/(M 3K_!=X&<6TU MVXV.8>3:AHD.0MT,N8=&5YP-+,_-,#:566/3<_.HW)#ZDE]E]^F8T( $BOJ M6>0#Q28"3H, ?&RDT:&(J734YL881RK1I[V0:D,NM$T M\&Y1*X:Z;Q5MJ2!)L\#)X,= 6ZFA%T/]%SY%_^=)ZE&8Y\HP7QB@ 0Q 1I( M TQ0":$)[6ML4+KP3K?4F[GAJM$>M8 W2E:^ JH#53 MW2N!.B;ZUP)K7G],-5 76&,]4&O<5?A?]7527L=.B^I;#DW@"R:QK?*C\AOG MF$!@^W%<7M+ U%")J.M^VOH 1RKW9Y".7Q592V);?7>G9AAIMV6E@Z#K0^^A MY1<.!Y9Q?3B;"FZP:Q+O*N-6[G^>OEJ^D\R_2OOTU?\!4$L#!!0 ( "N$ M-5==/EY8K 8 .TP 4 =W-T+3(P,C,P-#(U7W!R92YX;6S56EM/Y,82 M?N=7S)F\GF;Z?D$+$8?L'J%#LFB7*%%>1GVIGK'BL5';+/#O3]LP669A%0N/ MA/,R]K3+755??>ZJ+OO=CW>;PL@6TAS&Z+=CUKUS#[K4Y_%E_L[+*T;:S3 M!J&3_K:S^OH^%:MU.Z.8LJW8]FHZ\MI1CY5!6LF >- <&2TX(DQ'XC6UCIE_ MKXX,I\Q;XA#1@2&NB4$F!HN !1X#:$P8[2S]=M M>WVT6-S>WA[>N50>UFFUH!BSQ59Z_BA^]TS^EO72Q!BSZ*_^)=H4+PGF:\4-,51TP]>U-ZV/>I_:]?LNQ+=/[050]T0(A0QJ2_@$<=8=?_UTOFLQ-.WUVJ:-/?3U9M&)+,[J3(E+N^H,[B=H M[Z_A>-X4F^ORK[%U@G@\OVU:U 46_P11YXG*)3 M]EICX*Z%*L"#FUL]9>UWA,H.Y#IM[RRM@[(?708HEOW,IZYID_7M,E@1@Z<4 M*2,LX@P3I"E(1 +'&D=GJ+:[OG>&-]GR/B8-^,-5_661)UYT@'0G/3(]*L_4 M/:#S.KO?5VW1WI]E0),MSS,(=_^#^Z7R@8C\L"!+B4!< $.:18R\(5$002PU M-IG$^3G]4I0,KKRE:O3?Y9S'<9_2BQN+8I3X3\NBC#]NZ8ZLT^ MHM?6^\3R(6+9[ODLNQ\A)0@7#P'[KI>]BVU>=J&7'$.&[8I\E667CDH?>9 H M,IL74^,5LMD11 /STED:,#:C./!4VZ#0T^F&_M7(323BEY"*.KROPD\Y$R^U MS" H);(#C&3*9MNMP])X[CJE#PF"*FSI/]X3P)VGPH2OCE9N,@+26QUG.BD,:@\H9,YMH'VXBP=D E MCE2-3"3?:AQ$"#EU0KP2P4E$_\K>G8>,51&+ATWIUA$!PFEA$& />?5S@+2) M @EN!<$^,,+4'JCP'?6#>*&FSHM]8#L)DIR&D$/0/![R+A[(D@2IM5-YGQ0# M1UR!1L['[$F@."]U/*/F]T"0%U0/(H>>.CG&8CHE8ISETX_IJKZMEL1CG+TP MR).8TQ\0CQP#@:C51G(:E!7[J#^?*1Y$"O,/(<4K\9P2)?JZZ&.Z3/67HO*P MI-C)P$U>Y C+?N"\^F4L,"(JFDSO'&+81VGQLO9AG2K\#V''&&BG1)'+NFEM M^4=QW=?-WN?$IP0@A6VNG+PGN6YV$8P(S*QU$<>%'M M,"),N(DY'LPW9L/GNBQ\T1;5ZN=1E'ANH5C[HL6_IOZ][&"DFW*C<$ZS3(L=YT]Q >NH+UD:$H"V*4N9J MEPJ-=+ 6B>@ 2U#.A'%=R[^S8!A1)MRYW"O$;YU0P-_DI'A/J+LJVA*6F 1B MI"$(][9SHY 1F>_66.^P T9T')=.OM$XC X3[E6.@O"-PW^5;/&UL4$L! A0#% @ *X0U5UT^7EBL!@ M[3 !0 ( !D6( '=S="TR,#(S,#0R-5]P&UL4$L% 3!@ % 4 00$ &]I $! end